Highlights China SXT Pharmaceuticals, Inc.

Equities

SXTC

VGG2161P1403

Market Closed - Nasdaq Other stock markets 21:00:00 20/05/2024 BST			5-day change	1st Jan Change
1.21 ^USD	+5.22%		+16.35%	-69.52%

04-05	China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2023	CI
02-08	Wall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than Expected	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2023	04-05	CI
China SXT Pharmaceuticals to Implement 1-for-25 Reverse Stock Split	04/10/23	MT
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	31/07/23	CI
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2022	24/02/23	CI
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022	18/07/22	CI
China SXT Pharmaceuticals, Inc. Develops and Commercializes the Kuihuapan After-Soaking-Oral Tcmp and Zhudanfen Directly-Oral TCMP Products	14/01/22	CI
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2021	14/01/22	CI
China SXT Pharmaceuticals Receives Non-compliance Notice From Nasdaq	16/12/21	MT
China SXT Pharmaceuticals : Secures Manufacturing Permit for Freeze Drying of Traditional Chinese Medicine Preparations; Shares Rise	18/10/21	MT
China SXT Pharmaceuticals, Inc. Obtains New Pharmaceutical Manufacturing Permit and Passed Its GMP Compliance-Inspection	18/10/21	CI
China SXT Pharmaceuticals : Approves 1-for-4 Reverse Share Split; Shares Tumble Pre-Bell	19/02/21	MT
China SXT Pharmaceuticals, Inc. entered into a non-binding letter of intent to acquire 70% stake in Jiangsu Renji Pharmaceutical Chain Co., Ltd.	10/02/21	CI
China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2020	28/01/21	CI
China Sxt Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2020	31/07/20	CI
China Sxt Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2019	22/04/20	CI
China SXT Pharmaceuticals, Inc. Announces Plans to Increase Production of its Entire TCM Product Line	24/01/20	CI
China SXT Pharmaceuticals, Inc. Announces Regulatory Approval of its DNA Exam Laboratory from Jiangsu province Drug Administration	16/01/20	CI
China Sxt Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended March 31, 2019	15/08/19	CI
China SXT Pharmaceuticals, Inc. Announces TCM Homologous Supplements Production	03/07/19	CI
China SXT Pharmaceuticals, Inc. Reports Unaudited Consolidated Earnings Results for the Six Months Ended September 30, 2018	28/03/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights China SXT Pharmaceuticals, Inc.

Equities

SXTC

VGG2161P1403

Highlights

Filters